MoneyWorks4Me

Alembic Pharmaceuticals informs about annual secretarial compliance report

12 May 2022 Evaluate

Pursuant to Regulation 24A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD1/27/2019 dated 8th February, 2019, Alembic Pharmaceuticals has informed that it enclosed the Annual Secretarial Compliance Report issued by Samdani Shah & Kabra, Practicing Company Secretaries, for the financial year ended 31st March, 2022.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..